Accent Therapeutics Presents Data Supporting DHX9 Inhibition as a Novel Therapeutic Modality at American Association for Cancer Research (AACR) Annual Meeting 2023

Data support DHX9 inhibition as a novel therapeutic modality in microsatellite instable colorectal cancer and describe the first identification of potent and selective small molecule inhibitors of DHX9 Proprietary crystal structures of DHX9 enable rapid, structure-based drug discovery for…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.